A Phase I//II Study of Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination with Regional Positive Lymph Node Intensity-Modulated Radiotherapy for Locally Advanced Peripheral Non-Small Cell Lung Cancer
To evaluate the therapeutic results and toxicity of computed tomography (CT)-guided interstitial high-dose-rate (HDR) brachytherapy in combination with regional positive lymph node intensity-modulated radiotherapy(IMRT) for patients with locally advanced peripheral non-small cell lung cancer (NSCLC).
Source: Brachytherapy - Category: Cancer & Oncology Authors: Li Xiang, Sheng Lin, QingLian Wen, JianWen Zhang, PeiRong Ren, LiJia He, ChangLing Shang, HaoWen Pang, JingBo Wu Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | CT Scan | Intensity-Modulated Radiation Therapy | Lung Cancer | Non-Small Cell Lung Cancer | Study | Toxicology